IOVA
Iovance Biotherapeutics Inc
14.20$
-0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.8% | +48.3% | +4,250.5% | +88.2% | +25.9% | -33.1% | +21.5% | +12.5% | +28.6% | -17.7% | +39.0% | – | |
| – | +0.6% | +66.3% | +332.0% | +27.0% | +14.4% | +9.2% | +13.9% | -97.5% | -7,239.7% | – | +4,328.9% | – | |
| – | – | – | – | – | +50.3% | -101.5% | – | +1,908.7% | +183.6% | -62.4% | -23.0% | – | |
| – | -0.1% | -8.8% | -22.2% | +9.9% | +5.8% | +6.4% | +3.2% | -5.3% | -8.4% | -9.2% | +2.3% | – | |
| – | +82.9% | -83.2% | +378.9% | 0.0% | +48.4% | -82.0% | +256.4% | -8.3% | +5.3% | +7.0% | +0.8% | – | |
| – | +2.5% | -5.3% | -8.6% | +6.0% | +6.4% | +5.3% | -3.1% | +37.5% | +62.0% | -41.9% | -30.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -218.0% | – | -221.0% | – | -461.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.